Loading...
XHKG6118
Market cap36mUSD
Dec 23, Last price  
0.56HKD
1D
1.82%
1Q
1.82%
Jan 2017
-51.72%
IPO
-83.08%
Name

Austar Lifesciences Ltd

Chart & Performance

D1W1MN
XHKG:6118 chart
P/E
—
P/S
0.15
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
16.65%
Revenues
1.76b
-20.86%
705,153,000679,750,000627,544,000672,545,000546,933,000816,585,0001,049,021,0001,295,980,0002,015,028,0002,228,644,0001,763,734,000
Net income
-113m
L
53,571,00065,193,0006,384,000-18,670,000-54,085,000107,0008,091,00033,100,000277,300,00087,461,000-113,473,000
CFO
-63m
L+65.19%
71,407,000-64,400,99961,526,000-30,462,000-6,171,000-77,598,00037,793,00052,224,000-103,451,000-37,926,000-62,649,000
Dividend
May 19, 20150.05 HKD/sh

Profile

Austar Lifesciences Limited, an investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. It operates through six segments: Liquid and Bioprocess System; Clean Room and Automation Control and Monitoring System; Powder and Solid System; GMP Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment. The company offers liquid and bioprocess systems, including pharmaceutical water, and liquid preparation and bioprocess systems; powder and solid systems; clean utility equipment and systems; clean room, automation control, and monitor systems; and freeze-dryer, sterile filling, and visual inspection equipment. It also provides pharmaceutical process contamination control products; packaging and aseptic containment products; biosafety and lab animal equipment and consumables; laboratory one-stop solutions; and single-use bioprocess equipment and consumables. In addition, the company offers design, quality risk control, consulting, research and development support, process engineering, digitalization construction, after-sale, on-site, upgrading, relocation, and asset management services. Further, it is involved in the agency and distribution of pharmaceutical equipment, as well as provides assembly and pre-assembly services. The company was founded in 1991 and is headquartered in Shanghai, China.
URL
https://www.austar.com.cn/
IPO date
Nov 07, 2014
Employees
1,838
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,763,734
-20.86%
2,228,644
10.60%
2,015,028
55.48%
Cost of revenue
1,784,005
2,149,411
1,900,001
Unusual Expense (Income)
NOPBT
(20,271)
79,233
115,027
NOPBT Margin
3.56%
5.71%
Operating Taxes
379
18,741
46,601
Tax Rate
23.65%
40.51%
NOPAT
(20,650)
60,492
68,426
Net income
(113,473)
-229.74%
87,461
-68.46%
277,300
737.76%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
333,213
233,604
66,062
Long-term debt
228,504
117,322
99,130
Deferred revenue
544
746
Other long-term liabilities
42,826
(38,284)
(31,000)
Net debt
315,842
117,298
(94,252)
Cash flow
Cash from operating activities
(62,649)
(37,926)
(103,451)
CAPEX
(69,235)
(117,327)
(100,571)
Cash from investing activities
(54,467)
(153,143)
65,022
Cash from financing activities
147,115
125,301
59,349
FCF
(8,555)
(214,663)
(281,204)
Balance
Cash
173,765
148,129
219,741
Long term investments
72,110
85,499
39,703
Excess cash
157,688
122,196
158,693
Stockholders' equity
391,825
544,027
444,261
Invested Capital
1,156,810
1,079,826
766,570
ROIC
6.55%
11.64%
ROCE
6.39%
12.04%
EV
Common stock shares outstanding
512,582
512,582
512,582
Price
1.56
-22.77%
2.02
-86.60%
15.08
162.26%
Market cap
799,628
-22.77%
1,035,416
-86.60%
7,729,737
162.26%
EV
1,117,930
1,139,351
7,637,321
EBITDA
25,328
115,772
144,644
EV/EBITDA
44.14
9.84
52.80
Interest
13,961
10,247
4,402
Interest/NOPBT
12.93%
3.83%